Skip to content
Search

Latest Stories

Results for GPhC registration assessment announced

Results for GPhC registration assessment announced

More than 1,000 candidates sat the registration assessment on 2 November, 700 of them passed   

The General Pharmaceutical Council (GPhC) has published the results of the common registration assessment for aspiring pharmacists held on 2 November, 2023.


An overall pass rate of 66 per cent was recorded this year, as compared to 56 per cent in 2022 and 61 per cent in 2021.

A total of 1,067 candidates took the registration assessment, held jointly by the GPhC and Pharmaceutical Society of Northern Ireland (PSNI), of which 700 candidates cleared the assessment

In 2022, 937 candidates sat the registration assessment of which 525 passed the assessment.

Commenting on the results, GPhC Director of Education and Standards, Mark Voce, said: “I would like to congratulate all those who passed the November registration assessment and I look forward to them joining our register to continue to the next stage of their career.

“There will be candidates who unfortunately did not pass the assessment. If this is the case, the information on our website outlines all the possible options of what to do next.

“There is also advice available from the independent charity, Pharmacist Support, who can offer help with wellbeing and mental health, as well as practical support.

“For those who passed the registration assessment, I would like to wish them every success for the future,” he added.

Nearly half of the candidates (500) were first time sitters, while 457 were second time sitters, and 85 were third time sitters.

Candidates who passed the assessment include 303 first time sitters, 329 second time sitters, and 50 third time sitters.

The registration assessment papers are set by the Board of Assessors, an appointed body of pharmacists and assessment experts, according to the GPhC.

It assesses pharmacy graduates’ knowledge and skills to ensure safe and effective practice as pharmacists.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less